In PC, overexpression of IL-4Rα attenuates cell growth and migration after its expression is reduced by shRNA plasmids, and impaired IL-4 signaling in PC cells enhances the inhibition of xenograft tumors (109), suggesting that IL-4Rα is a promising therapeutic target. This evidence concerns the gene IL4R and pachyonychia congenita.